A mutant, human ferroportin-1 protein and encoding nucleic acid are provided. The mutant ferroportin-1 protein has a deletion of valine 162 compared to wild-type ferroportin-1 protein. The mutant protein and nucleic acid may be useful in detection of a predisposition to iron overload disorders such as haemochromatosis. Furthermore, it is proposed that the valine 162 deletion is a loss-of-function mutation that may underlie iron overload disorders such as haemochromatosis. Therefore, methods of both diagnosis and treatment of haemochromatosis are provided.
申请公布号
WO03029287(A1)
申请公布日期
2003.04.10
申请号
WO2002AU01335
申请日期
2002.10.01
申请人
THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICALRESEARCH;WALLACE, DANIEL;ARDEN, KATHERINE;PEDERSEN, PALLE;SUBRAMANIAM, NATHAN